Benzonatate Capsule
Product Images NDC 51655-776

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 51655-776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Benzonatate showing its molecular formula C30H53NO11 with aromatic ring and attached functional groups, including an ethylamine side chain and polyether chains.*
FDA Label Image

Label (51655 776 54 Rev A 07 20 Nhc)

Label (51655 776 54   Rev A 07 20 Nhc)
Label for Benzonatate capsules USP 200 mg by Northwind Health Company, LLC. The label displays the NDC 51655-776-54 and indicates 15 capsules per package. It includes storage instructions at 20°-25°C (68°-77°F), pediatric storage warnings, and a note that the capsules should be swallowed whole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.